Search results

Filters

  • Journals
  • Authors
  • Keywords
  • Data
  • Type

Search results

Number of results: 7
items per page: 25 50 75
Sort by:
Download PDF Download RIS Download Bibtex

Abstract

Since late 2011, porcine infections with highly virulent and antigenic variant of pseudorabies virus (PRV) cause great economic loss in the swine industry in China, and its emergence leads to variable protection efficacy of the commercially available PRV vaccine.

In the present study, the potential cross-protective efficacy of two live virus vaccines, includ- ing a commercial vaccine, and an attenuated low pathogenic PRV variant (rPRVTJ-delTK/gE/gI) against a PRV variant Tianjing (TJ) was evaluated in piglets. Vaccination of piglets with the live vaccine Bartha-K61 could not reduce the clinical signs, and was partially efficacious in the reduc- tion of viral loads upon PRV variant TJ challenge, indicating that this live vaccine provided limited cross-protection efficacy against the PRV variant infection. Additionally, rPRVTJ-delTK/gE/gI appeared to exert some beneficial efficiency in shortening the period of clinical fever and improv- ing the growth performance of the challenged pigs.

Our findings give a valuable guidance for the choice and use of PRV vaccines to control PRV variant infection in the field.

Go to article

Authors and Affiliations

M. Wang
L. Wang
Q. Zhao
Download PDF Download RIS Download Bibtex

Abstract

Based on the rolling bearing vibration measurement principle in ISO standard, a nonlinear dynamic model of ball bearing is built and motion equations of the inner ring, outer ring, and rolling elements are derived by using Lagrange’s equation. The ball bearing model includes the influence of waviness, rotational speed, external load, arbor supporting stiffness and arbor eccentricity. Ball bearing high-speed vibration tests are performed and used to verify the theoretical results. Simulated results showed that specific waviness orders produced the principal frequencies that were proportional to rotational speed. Rotational speed mainly affected the value of the natural frequency of the bearing system, and RMS (Root Mean Square) of the full band had a great fluctuation with the increase of rotational speed. In the experiment, spectrum and RMS of 2fs-30 kHz (fs: the rotational frequency of inner ring/arbor) under high speed could include not only the influence of rotational speed but also principal frequencies produced by waviness, which could cover the part of requirements of the standard bearing vibration measurement.

Go to article

Authors and Affiliations

P.P Hou
L.Q. Wang
Q.Y. Peng
Download PDF Download RIS Download Bibtex

Abstract

Vaccination is a common routine for prevention and control of human and animal diseases by inducing antibody responses and cell-mediated immunity in the body. Through vaccinations, smallpox and some other diseases have been eradicated in the past few years. The use of a patho- gen itself or a subunit domain of a protein antigen as immunogens lays the basis for traditional vaccine development. But there are more and more newly emerged pathogens which have expe- rienced antigenic drift or shift under antibody selective pressures, rendering vaccine-induced im- munity ineffective. In addition, vaccine development has been hampered due to problems includ- ing difficulties in isolation and culture of certain pathogens and the antibody-dependent enhancement of viral infection (ADE). How to induce strong antibody responses, especially neu- tralizing antibody responses, and robust cell-mediated immune responses is tricky. Here we re- view the progress in vaccine development from traditional vaccine design to reverse vaccinology and structural vaccinology and present with some helpful perspectives on developing novel vac- cines.

Go to article

Authors and Affiliations

Y.B. Wang
L.P. Wang
P. Li
Download PDF Download RIS Download Bibtex

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be a major public health concern. Nucleocapsid (N) protein is the most abundant structural protein on SARS-CoV-2 virions and induces the production of antibodies at the early stage of infection. Large-scale preparation of N protein is essential for the development of immunoassays to detect antibodies to SARS-CoV-2 and the control of virus transmission. In this study, expression of water-soluble N protein was achieved through inducing protein expression at 25°C with 0.5 mM IPTG for 12 h. Western blot and ELISA showed that recombinant N protein could be recognized by sera collected from subjects immunized with Sinovac inactivated SARS-CoV-2 vaccine. Four monoclonal antibodies namely 2B1B1, 4D3A3, 5G1F8, and 7C6F5 were produced using hybridoma technology. Titers of all four monoclonal antibodies in ELISA reached more than 1.28×10 6.0. Moreover, all monoclonal antibodies could react specifically with N protein expressed by transfection of pcDNA3.1-N into BHK-21 cells in IPMA and IFA. These results indicated that water-soluble N protein retained high immunogenicity and possessed the same epitopes as that of native N protein on virions. In addition, the preparation of water-soluble N protein and its monoclonal antibodies laid the basis for the development of immunoassays for COVID-19 detection.
Go to article

Bibliography

1. Bai Z, Cao Y, Liu W, Li J (2021) The SARS-CoV-2 nucleocapsid protein and its role in viral structure, biological functions, and a poten-tial target for drug or vaccine mitigation. Viruses 13: 1115.
2. Bates TA, Weinstein JB, Farley S, Leier HC, Messer WB, Tafesse FG (2021) Cross-reactivity of SARS-CoV structural protein antibod-ies against SARS-CoV-2. Cell Rep 34: 108737.
3. Chen K, Xiao F, Hu D, Ge W, Tian M, Wang W, Pan P, Wu K, Wu J (2020) SARS-CoV-2 nucleocapsid protein interacts with RIG-I and represses RIG-mediated IFN-β production. Viruses 13: 47.
4. Chen Y, Liu Q, Guo D (2020) Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol 92: 418-423.
5. Clementi N, Ghosh S, De Santis M, Castelli M, Criscuolo E, Zanoni I, Clementi M, Mancini N (2021) Viral respiratory pathogens and lung injury. Clin Microbiol Rev 34: e00103-00120.
6. Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, Dela Cruz CS, Wang Y, Wu C, Xiao Y, Zhang L, Han L, Dang S, Xu Y, Yang QW, Xu SY, Zhu HD, Xu Y,C Jin Q, Sharma L, Wang L, Wang J (2020) Profiling early humoral response to diagnose novel corona-virus disease (COVID-19). Clin Infect Dis 71: 778-785.
7. Gutiérrez-González M, Farías C, Tello S, Pérez-Etcheverry D, Romero A, Zúñiga R, Ribeiro CH, Lorenzo-Ferreiro C, Molina MC (2019) Optimization of culture conditions for the expression of three different insoluble proteins in Escherichia coli. Sci Rep 9: 16850.
8. Han Y, Luo Z, Zhai W, Zheng Y, Liu H, Wang Y, Wu E, Xiong F, Ma Y (2020) Comparison of the clinical manifestations between dif-ferent age groups of patients with overseas imported COVID-19. PLoS One 15: e0243347.
9. Ji T, Liu Z, Wang G, Guo X, Akbar khan S, Lai C, Chen H, Huang S, Xia S, Chen B, Jia H, Chen Y, Zhou Q (2020) Detection of COVID-19: A review of the current literature and future perspectives. Biosens Bioelectron 166: 112455.
10. Jin Q, Yang J, Lu Q, Guo J, Deng R, Wang Y, Wang S, Wang S, Chen W, Zhi Y, Wang L, Yang S, Zhang G (2012) Development of an immunochromatographic strip for the detection of antibodies against Porcine circovirus-2. J Vet Diagn Invest 24: 1151-1157.
11. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G (2020) Virology, epidemiology, pathogenesis, and control of COVID-19. Vi-ruses 12: 372.
12. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J (2020) The incubation period of coro-navirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 172: 577-582.
13. Leung NH (2021) Transmissibility and transmission of respiratory viruses. Nat Rev Microbiol 19: 528-545.
14. Liao M, Yan J, Wang X, Qian H, Wang C, Xu D, Wang B, Yang B, Liu S, Zhou M, Gao Q, Zhou Q, Luo J, Li Z, Liu W (2020) De-velopment and clinical application of a rapid SARS-CoV-2 antibody test strip: A multi-center assessment across China. J Clin Lab Anal 35: e23619.
15. Liu P, Zong Y, Jiang S, Jiao Y, Yu X (2021) Development of a nucleocapsid protein-based ELISA for detection of human IgM and IgG antibodies to SARS-CoV-2. ACS Omega 6: 9667-9671.
16. Lv Y, Ma Y, Si Y, Zhu X, Zhang L, Feng H, Tian D, Liao Y, Liu T, Lu H, Ling Y (2021) Rapid SARS-CoV-2 antigen detection poten-tiates early diagnosis of COVID-19 disease. Biosci Trends 15: 93-99.
17. Mak GC, Cheng PK, Lau SS, Wong KK, Lau CS, Lam ET, Chan RC, Tsang DN (2020) Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J Clin Virol 129: 104500.
18. Malik YA (2020) Properties of coronavirus and SARS-CoV-2. Malays J Pathol 42: 3-11.
19. Meyer NJ, Gattinoni L, Calfee CS (2021) Acute respiratory distress syndrome. Lancet 398: 622-637.
20. Okba NM, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Hingrat QL, Descamps D, Houhou-Fidouh N, Reusken CB, Bosch BJ, Drosten C, Koopmans MP, Haagmans BL (2020) Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients. Emerg Infect Dis 26: 1478-1488.
21. Rump A, Risti R, Kristal ML, Reut J, Syritski V, Lookene A, Boudinot SR (2021) Dual ELISA using SARS-CoV-2 nucleocapsid pro-tein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation. Biochem Biophys Res Commun 534: 457-460.
22. Singh A, Upadhyay V, Upadhyay AK, Singh SM, Panda AK (2015) Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process. Microb Cell Fact 14: 41.
23. Tian Y, Zhang G, Liu H, Ding P, Jia R, Zhou J, Chen Y, Qi Y, Du J, Liang C, Zhu X, Wang A (2022) Screening and identification of B cell epitope of the nucleocapsid protein in SARS-CoV-2 using the monoclonal antibodies. Appl Microbiol Biotechnol 106: 1151-1164.
24. Vashisht K, Goyal B, Pasupureddy R, Na BK, Shin HJ, Sahu D, De S, Chakraborti S, Pandey KC (2023) Exploring the immunodomi-nant epitopes of SARS-CoV-2 nucleocapsid protein as exposure biomarker. Cureus 15: e34827.
25. Wang Y, Liu X, Tao L, Xu P, Gao X, Li H, Yang Z, Wu W (2017) Expression and immunogenicity of VP40 protein of ZEBOV. Arch Iran Med 20: 246-250.
26. Wang YB, Li YH, Li QM, Xie WT, Guo CL, Guo JQ, Deng RG, Zhang GP (2019) Development of a blocking immunoperoxidase monolayer assay for differentiation between pseudorabies virus-infected and vaccinated animals. Pol J Vet Sci 44: 717-723.
27. Zeng W, Liu G, Ma H, Zhao D, Yang Y, Liu M, Mohammed A, Zhao C, Yang Y, Xie J, Ding C, Ma X, Weng J, Gao Y, He H, Jin T (2020) Biochemical characterization of SARS-CoV-2 nucleocapsid protein. Biochem Biophys Res Commun 527: 618-623.
28. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579: 270-273.
Go to article

Authors and Affiliations

Y.B. Wang
1
S.W. Wang
2
Q.Y. Jin
3
L.P. Chen
4
F.Q. Zhang
1
J.J. Shi
1
Y. Yin
5
Z.X. Fan
1
X.Y. Liu
6
L.P. Wang
6
P. Li
6

  1. School of Public Health, Xinxiang Medical University, Xinxiang 453003, P.R. China
  2. School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, P.R. China
  3. Henan Provincial Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, P.R. China
  4. Gushi County Center for Animal Disease Control and Prevention, Xinyang 465200, P.R. China
  5. Mingde College of Xinxiang Medical University, Xinxiang 453003, P.R. China
  6. School of Biological Engineering, Xinxiang University, Xinxiang 453003, P.R. China

This page uses 'cookies'. Learn more